Norges Bank acquired a new position in Gilead Sciences shares, triggering institutional ownership filing requirements with the SEC.
1 report, 1 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Norges Bank acquired a new position in Gilead Sciences shares, triggering institutional ownership filing requirements with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Gilead Sciences
American company
- Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.
- A pilot program is underway involving the federal government, Benue State, and Gilead Sciences, with the state participating in the drug supply management.
-
Norges Bank
central bank of Norway
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Doximity filed with the Securities and Exchange Commission reporting changes in company ownership.
- Royal Bank of Canada filed with the Securities and Exchange Commission regarding institutional ownership disclosures on May 28, 2026.
- Norges Bank purchased a new position in AbbVie stock, leading to a required institutional holdings disclosure filed with the SEC on July 2, 2026.
- Sysco Corporation filed required documents with the Securities and Exchange Commission regarding ownership changes on August 30, 2026.
- Dynatrace filed required documents with the Securities and Exchange Commission regarding institutional holdings.